Development code · Small Molecule
SP-624
SP-624 is a development code for Forvisirvat, developed by Sirtsei Pharmaceuticals, Inc..
- Status
- Phase 2/3 for Major depressive disorder
- Mechanism
- SIRT6 Activator
- Developer
- Sirtsei Pharmaceuticals, Inc.
Programs
- Forvisirvat for Major depressive disorderPhase 2/3Active
Also known as
- SP 624
- SP624
- forvisirvat
- DS-7830A
- 2135638-06-9
- (2S,5'R)-7-chloro-3',4-dimethoxy-5'-methyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione